Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Illumina    ILMN

ILLUMINA

(ILMN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/16/2019 07/17/2019 07/18/2019 07/19/2019 07/22/2019 Date
302.3(c) 302.9(c) 298.55(c) 293.2(c) 298.28(c) Last
1 840 869 1 270 059 1 620 592 1 733 987 1 128 081 Volume
0.00% +0.20% -1.44% -1.79% +1.73% Change
More quotes
Financials (USD)
Sales 2019 3 622 M
EBIT 2019 1 062 M
Net income 2019 923 M
Finance 2019 2 582 M
Yield 2019 -
Sales 2020 4 128 M
EBIT 2020 1 268 M
Net income 2020 1 075 M
Finance 2020 3 395 M
Yield 2020 -
P/E ratio 2019 48,3x
P/E ratio 2020 41,7x
EV / Sales2019 11,4x
EV / Sales2020 9,80x
Capitalization 43 847 M
More Financials
Company
Illumina specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and... 
More about the company
Surperformance© ratings of Illumina
Trading Rating : Investor Rating :
More Ratings
Latest news on ILLUMINA
07/17EXCLUSIVE : Woodford biotech stakes first off block in asset sale - source
RE
07/16ILLUMINA : Expands Genomics Accelerator to Cambridge, UK
BU
07/15Stocks to Watch: Circor International, Callon Petroleum, American Airlines, B..
DJ
07/15Stocks to Watch: Boeing, Gilead Sciences, Facebook, J&J and More
DJ
07/12Ford, Milacron rise; Illumina, US Xpress fall
AQ
07/12Wall St. notches all-time highs on lingering rate-cut optimism
RE
07/12MARKET SNAPSHOT: S&P 500, Dow, Nasdaq Close At Record Levels Again As Bulls B..
DJ
07/11ILLUMINA INC : Results of Operations and Financial Condition, Financial Statemen..
AQ
07/11ILLUMINA : Reports Preliminary Revenue for Second Quarter of Fiscal Year 2019
BU
06/28ILLUMINA : Files Patent Infringement Suits Related to BGI in Switzerland, Turkey..
BU
More news
Analyst Recommendations on ILLUMINA
More recommendations
Stock Trading Strategies
ILLUMINA - 2018
Underpinned by a support level
BUY
More Stock Trading Analysis
Sector news : Advanced Medical Equipment & Technology - NEC
04:20pDANAHER : Envista Holdings Corp. Files for IPO
DJ
11:43aROYAL PHILIPS : Up Over 6%, on Pace for Largest Percent Increase in Over Two Yea..
DJ
04:53aROYAL PHILIPS : Philips sales spurred by rising Chinese healthcare spending
RE
04:53aROYAL PHILIPS : Philips sales spurred by rising Chinese healthcare spending
RE
01:35aROYAL PHILIPS : 2Q Net Profit Beat Views as Sales Rose
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
Chart ILLUMINA
Duration : Period :
Illumina Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ILLUMINA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 334,38  $
Last Close Price 298,28  $
Spread / Highest target 28,1%
Spread / Average Target 12,1%
Spread / Lowest Target -6,13%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Ostadan Omead Executive Vice President-Products & Operations
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA-0.55%43 100
THERMO FISHER SCIENTIFIC29.51%115 923
DANAHER CORPORATION37.33%101 586
INTUITIVE SURGICAL10.42%61 050
BOSTON SCIENTIFIC CORPORATION19.55%58 755
EDWARDS LIFESCIENCES CORPORATION26.87%40 518